Active Stocks
Thu Feb 13 2025 15:56:24
  1. Tata Steel share price
  2. 136.20 2.99%
  1. Tata Motors share price
  2. 683.65 -0.11%
  1. Wipro share price
  2. 308.50 -0.55%
  1. State Bank Of India share price
  2. 727.30 -0.81%
  1. NTPC share price
  2. 306.95 0.23%
Business News/ Markets / Ipo/  Dr Agarwal's Healthcare Share Price Highlights: Stock ends at 400.25 apiece on NSE, 0.44% discount to IPO price
BackBack

Dr Agarwal's Healthcare Share Price Highlights: Stock ends at ₹400.25 apiece on NSE, 0.44% discount to IPO price

Dr Agarwal's Healthcare Share Price Highlights: Dr Agarwal's Healthcare share price ended listing day at 400.25 on NSE, a 0.44% discount to the IPO price of 402, and at 401.55 on BSE, a 0.11% discount. Dr. Agarwal's Healthcare IPO was subscribed 1.55 times on its final bidding day.

Dr Agarwal's Healthcare Share Price Highlights: Dr Agarwal's share price lists on the bourses today.Premium
Dr Agarwal's Healthcare Share Price Highlights: Dr Agarwal's share price lists on the bourses today.

Dr Agarwal's Healthcare Share Price Highlights: Dr Agarwal's Healthcare share price made a muted debut on the bourses today. On NSE, Dr Agarwal's Healthcare share price opened at 402 per share, same as the IPO price. On BSE, Dr Agarwal's Healthcare share price today opened at 396.90 apiece, down 1.27% than the issue price.

Dr Agarwal's Healthcare share price ended listing day at 400.25 on NSE, a 0.44% discount to the IPO price of 402, and at 401.55 on BSE, a 0.11% discount.

Arun Kejriwal, the founder of Kejriwal Research and Investment Services, advised that if potential investors chose not to apply for this issue, they would not have received shares; if they had applied, they would have secured some stock. Therefore, if you refrained from applying and are now tempted by the price, it's advisable to wait until we approach the one-month mark before deciding whether to invest in the shares.

The equity shares of Dr Agarwal’s Health Care Ltd debuted on the Indian stock market today (Tuesday, February 4) after the initial public offering (IPO) garnered a tepid response. 

The public offering was open for subscription from January 29 through January 31, with the IPO allotment finalized on February 3. Dr Agarwal’s Healthcare shares were listed on both the BSE and NSE stock exchanges.

Dr. Agarwal's Healthcare IPO concluded with a subscription rate of 1.55 times on its final bidding day, which was Friday. The segment allocated for Qualified Institutional Buyers (QIBs) saw a subscription of 4.64 times, while Retail Individual Investors (RIIs) subscribed at a rate of 41 percent. The share reserved for non-institutional investors was subscribed 39 percent.

 The public offering has a price range set between 382 and 402 per share. This IPO consists of a fresh issue of shares totaling up to 300 crore and an Offer For Sale (OFS) of approximately 6.78 crore equity shares, amounting to 2,727.26 crore, from promoters and other selling shareholders at the highest price point. 

Dr. Agarwal's Health Care provides a broad spectrum of services, which encompasses cataract, refractive, and various other surgical procedures, along with consultations, diagnostics, non-surgical treatments, and sales of optical products, contact lenses, accessories, and medications related to eye care.

Stay tuned for more updates 

04 Feb 2025, 04:16:09 PM IST

Dr Agarwal's Healthcare Share Price Highlights: Stock ends at ₹400.25 apiece on NSE, 0.44% discount to IPO price

Dr Agarwal's Healthcare share price ended listing day at 400.25 on NSE, a 0.44% discount to the IPO price of 402, and at 401.55 on BSE, a 0.11% discount

04 Feb 2025, 03:21:18 PM IST

Dr Agarwal's Healthcare Share Price Live Updates: Check Arun Kejriwal's post-listing views

Arun Kejriwal, the founder of Kejriwal Research and Investment Services, elaborated on the situation regarding Dr. Agarwal's Healthcare Share Price, noting that there was a lack of strong interest from both high-net-worth individuals (HNI) and retail investors, including some employees. The issue was rescued by qualified institutional buyers (QIBs). Although they were able to launch the shares at the initial price, the stock is currently facing downward pressure. The selling pressure will arise from institutional investors who were persuaded to invest, and this will intensify with each passing day if the share price fails to exceed the issue price. When does the stock face genuine pressure? 

This occurs when the month concludes and the shares allotted to anchor investors become available for sale. If the shares have not rebounded by then, another wave of selling pressure may occur. If potential investors chose not to apply for this issue, they would not have received shares; if they had applied, they would have secured some stock. Therefore, if you refrained from applying and are now tempted by the price, it's advisable to wait until we approach the one-month mark before deciding whether to invest in the shares.

04 Feb 2025, 02:53:56 PM IST

Dr Agarwal's Healthcare Share Price Live Updates: Check out key risks 

  • Retention of qualified and experienced doctors is a big risk
  • Brand and reputation are key in a hospital business
  • Geographical concentration
  • The company exposed to legal claims and regulatory actions arising from the provision of healthcare services

04 Feb 2025, 02:32:10 PM IST

Dr Agarwal's Healthcare Share Price Live Updates: Industry Outlook

According to the CRISIL MI&A Report, the eye care market in India has grown at a compounded annual growth rate of 11.5% between the Financial Years 2019 and 2024 to reach the value of 378 billion in the Financial Year 2024. This market includes surgical and non-surgical treatments for patients suffering from various eye disorders.

04 Feb 2025, 01:54:12 PM IST

Dr Agarwal's Healthcare Share Price Live Updates: Stock Check

The stock was trading at 399.50 per share on NSE, marking a 0.62% decrease at 13:51 IST, and at 399 per share on BSE,  up 0.53%.  

04 Feb 2025, 01:41:37 PM IST

Dr Agarwal's Healthcare Share Price Live Updates: Check out IPO details 

Dr Agarwal’s Healthcare IPO consists of a fresh equity share issuance valued at 300 crore, along with an offer-for-sale of 6.78 crore shares amounting to 2,727.3 crore from the current shareholders.

In addition to the promoters, the selling shareholders in the offer-for-sale include Arvon Investments Pte and Claymore Investments Mauritius Pte, both of which are owned by the private equity firm Temasek Holdings, as well as Hyperion Investments Pte, which is owned by the US private equity firm TPG.

Public shareholders, such as Arvon Investments Pte (12.44% stake), Claymore Investments Mauritius Pte (15.71%), and Hyperion Investments Pte (33.70% stake), own the remaining shares of the company, with the promoters owning 37.73%.

04 Feb 2025, 01:11:19 PM IST

Dr Agarwal's Healthcare Share Price Live Updates: All you need to know about marquee shareholders

The firm's marquee institutional shareholders include Temasek Holdings (Private) Ltd (through its subsidiaries, Arvon Investments Pte. Ltd. and Claymore Investments (Mauritius) Pte. Ltd.) and TPG (through Hyperion Investments Pte. Ltd.).

04 Feb 2025, 12:51:14 PM IST

Dr Agarwal's Healthcare Share Price Live Updates: All you need to know about ‘hub-and-spoke’ model

The company’s ‘hub-and-spoke’ model categorizes facilities as Primary (nonsurgical), Secondary (surgical), and Tertiary (super-specialty). This model supports high patient volumes and economies of scale, enhancing accessibility and efficiency.

04 Feb 2025, 12:35:50 PM IST

Dr Agarwal's Healthcare Share Price Live Updates: Stock Check 

The stock was trading at 378.05 per share on NSE, marking a 5.96% decrease at 12:33 IST, and at 377.60 per share on BSE, showing a nearly 4.86% decline.

04 Feb 2025, 12:15:51 PM IST

Dr Agarwal's Healthcare Share Price Live Updates: Check out peer list 

As per the red herring prospectus (RHP), the firm's listed peers are Apollo Hospitals Enterprise (with a P/E of 107.11), Max Healthcare Institute (with a P/E of 95.88), Fortis Healthcare (with a P/E of 82.11), Global Health (with a P/E of 57.49), Narayana Hrudayalaya (with a P/E of 33.14), Krishna Institute of Medical Sciences (with a P/E of 79.79), Aster DM Healthcare (with a P/E of 136.07), and Rainbow Children's Medicare (with a P/E of 67.90).

04 Feb 2025, 11:51:00 AM IST

Dr Agarwal's Healthcare Share Price Live Updates: All you need to know about the Indian eye care industry

According to IAPB, India has the highest number of visually impaired people in the world as nearly 1 out of every 5 individuals in India face vision loss disorder. There is a high burden across eye related ailments and diseases in India with increasing need for medical intervention. Because of high prevalence of eye disorder in India population, eye care is an integral part of the Indian health care system. The eye care market in India has grown at CAGR of 11.5% between Financial Year 2019 and 2024 to reach the value of 378 billion in Financial Year 2024.

04 Feb 2025, 11:20:29 AM IST

Dr Agarwal's Healthcare Share Price Live Updates: Key Strengths

  • Largest eye care services provider in India with a trusted brand
  • End-to-end, comprehensive eye care services offering
  • Scalable, asset-light, hub-and-spoke operating model
  • Proven clinical excellence driven by a strong clinical board and history of surgical innovations

04 Feb 2025, 10:59:48 AM IST

Dr Agarwal's Healthcare Share Price Live Updates: Sagar Shetty, Research Analyst, StoxBox says avoid investing into the shares in the short term

Dr. Agarwal Health Care Ltd made a flat debut into the bourses, which remained largely in line with our expectations. The IPO saw a modest subscription rate of 1.49 times, with weak market sentiment and concerns over valuation weighing on investor interest. The concerns were further compounded by its lower profitability, and significant promoter exit via the offer for sale (OFS). We thus recommend investors to avoid investing into the shares in the short term and keep a track of its performance in the upcoming quarter.

04 Feb 2025, 10:34:36 AM IST

Dr Agarwal's Healthcare Share Price Live Updates: Here's what Prashanth Tapse says about the share debut

Prashanth Tapse, Sr VP Research – Research Analyst at Mehta Equities Ltd, said that despite markets in recovering mood, Dr Agarwal eye listing was in line with our expectations with neutral and negative opening. The offer received modest subscription demand from all investors except QIB while other categories like NII, retail and employee quota were subscribed below 1x. The listing is justified on the back of 90% ofs offer living less value for investors on table.

Considering the market mood, we recommend allotted investors to continue holding it for long term despite knowing that post listing will invite short term volatility, hence advice for non-allotted investors, to wait and watch for better pricing.

04 Feb 2025, 10:20:36 AM IST

Dr Agarwal's Healthcare Share Price Live Updates: Stock Check 

The stock was trading at 395.50 per share on NSE, marking a 1.62% decrease at 10:19 IST, and at 393.25 per share on BSE, showing a nearly 0.92% decline.

04 Feb 2025, 10:00:02 AM IST

Dr Agarwal's Healthcare Share Price Live Updates: Stock makes a muted debut, opens at ₹402 on NSE, same as IPO price

Dr Agarwal's Healthcare share price made a muted debut on the bourses today. On NSE, Dr Agarwal's Healthcare share price opened at 402 per share, same as the IPO price. On BSE, Dr Agarwal's Healthcare share price today opened at 396.90 apiece, down 1.27% than the issue price.

04 Feb 2025, 09:35:37 AM IST

Dr Agarwal's Healthcare Share Price Live Updates: Check out StoxBox's expert views on the listing 

“We anticipate Dr Agarwal's Health Care Ltd (DACHL) to have a rather dull market debut due to several concerns. The muted premium on its issue primarily reflects weak market sentiment, emphasizing its high valuation, lower profitability, and significant promoter exit via the offer for sale (OFS). Considering these factors, along with a lower subscription rate of 1.5x, we advise participants to avoid the issue. We will reassess our rating based on the company's sustained business performance in the upcoming quarters," said Sagar Shetty, Research Analyst, StoxBox.

04 Feb 2025, 09:19:22 AM IST

Dr Agarwal's Healthcare Share Price Live Updates:  IPO reservations 

Dr Agarwal's Healthcare IPO has reserved not more than 50% of the shares in the public issue for qualified institutional buyers (QIB), not less than 15% for non-institutional Institutional Investors (NII), and not less than 35% of the offer is reserved for retail investors. The employee portion has been reserved up to 1,579,399 equity shares, and the shareholders have been reserved up to 1,129,574.

04 Feb 2025, 09:11:28 AM IST

Dr Agarwal's Healthcare Share Price Live Updates: Here's what Prashanth Tapse, Sr VP Research – Research Analyst at Mehta Equities Ltd says 

Considering the market trend and volatility, we are expecting a flat to negative listing of its issue price. Post listing, we also expect to see short term volatility, hence advice for non-allotted investors, to wait and watch. While allotted long term investors can continue to HOLD for long term perspective only.

04 Feb 2025, 09:01:47 AM IST

Dr Agarwal's Healthcare Share Price Live Updates: All you need to know about the Special Pre-open Session

Dr. Agarwal’s Health Care shares will be a part of Special Pre-open Session (SPOS) on Tuesday, February 4, it added, and the stock will be available for trading from 10:00 AM.

04 Feb 2025, 08:46:49 AM IST

Dr Agarwal's Healthcare Share Price Live Updates: Here's what Dr Agarwal's Healthcare IPO GMP today hint ahead of the debut

Dr Agarwal's IPO GMP today is -4. This indicates Dr Agarwal's Healthcare share price was trading at a discount of 4 in the grey market, according to investorgain.com.

Considering the upper end of the IPO price band and the current discount in the grey market, the estimated listing price of Dr Agarwal's Healthcare share price is indicated at 398 apiece, which is 1% lower than the IPO price of 402.

Grey market activity over the past 12 sessions indicates that today's IPO GMP is trending toward a discount and anticipates a bargain listing. Experts on investorgain.com say that the greatest GMP is 54, while the lowest is -4.00.

'Grey market premium' indicates investors' readiness to pay more than the issue price.

Disclaimer: The views and recommendations above are those of individual analysts, experts and broking companies, not of Mint. We advise investors to check with certified experts before making any investment decision.

Recommended For You
GENIE RECOMMENDS

Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!

Let’s get started